{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T01:23:31Z","timestamp":1780881811941,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["25\\u2013114"],"award-info":[{"award-number":["25\\u2013114"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["114"],"award-info":[{"award-number":["114"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jiac.2019.05.004","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T01:43:57Z","timestamp":1559180637000},"page":"931-935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rabies post-exposure prophylactic vaccination for returning travelers to Japan"],"prefix":"10.1016","volume":"25","author":[{"given":"Kei","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8150-075X","authenticated-orcid":false,"given":"Mugen","family":"Ujiie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Fujiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoko","family":"Mawatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kutsuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzo","family":"Kanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.05.004_bib1","first-page":"201","article-title":"Rabies vaccines: WHO position paper","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jiac.2019.05.004_bib2","doi-asserted-by":"crossref","first-page":"882","DOI":"10.11150\/kansenshogakuzasshi1970.76.882","article-title":"Anti-rabies antibody titers among subjects who received rabies post-exposure prophylaxis with foreign-made rabies vaccines at the beginning and followed with Japanese rabies vaccine","volume":"76","author":"Takayama","year":"2002","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.jiac.2019.05.004_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.11150\/kansenshogakuzasshi1970.72.1046","article-title":"Anti-rabies antibody levels observed in subjects who were bitten by supposed rabid animals abroad and received post-exposure immunization","volume":"72","author":"Takayama","year":"1998","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.jiac.2019.05.004_bib4","series-title":"Laboratory techniques in rabies","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.jiac.2019.05.004_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1439-0450.2003.00627.x","article-title":"Immune response to Japanese rabies vaccine in domestic dogs","volume":"50","author":"Shimazaki","year":"2003","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"10.1016\/j.jiac.2019.05.004_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1440-1827.2009.02406.x","volume":"59","author":"Tobiume","year":"2009","journal-title":"Pathol Int"},{"key":"10.1016\/j.jiac.2019.05.004_bib7","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1016\/j.vaccine.2009.09.029","article-title":"Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals","volume":"27","author":"Rupprecht","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2019.05.004_bib8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1017\/S0950268800066619","article-title":"Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis","volume":"99","author":"Suntharasamai","year":"1987","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jiac.2019.05.004_bib9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1017\/S0022172400066286","article-title":"Purified Vero cell rabies vaccine and human diploid cell strain vaccine: comparison of neutralizing antibody responses to post-exposure regimens","volume":"96","author":"Suntharasamai","year":"1986","journal-title":"J\u00a0Hyg (Lond)"},{"key":"10.1016\/j.jiac.2019.05.004_bib10","series-title":"Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.jiac.2019.05.004_bib11","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/S0264-410X(02)00188-3","article-title":"Antibody responses induced by immunization with a Japanese rabies vaccine determined by neutralization test and enzyme-linked immunosorbent assay","volume":"20","author":"Arai","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2019.05.004_bib12","series-title":"Principles of vaccination. Epidemiology and prevention of vaccine-preventable diseases","first-page":"1","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"10.1016\/j.jiac.2019.05.004_bib13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.vaccine.2013.12.019","article-title":"Incidence and variables associated with inadequate antibody titers after pre-exposure rabies vaccination among veterinary medical students","volume":"32","author":"Banga","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2019.05.004_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0264-410X(92)90029-J","article-title":"Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine","volume":"10","author":"Briggs","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2019.05.004_bib15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0264-410X(00)00342-X","article-title":"Purified chick embryo cell culture rabies vaccine: interchangeability with human diploid cell culture rabies vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons","volume":"19","author":"Briggs","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2019.05.004_bib16","first-page":"1","article-title":"Human rabies prevention\u2014United States. Recommendations of the advisory committee on immunization practices","volume":"57","year":"2008","journal-title":"MMWR"},{"key":"10.1016\/j.jiac.2019.05.004_bib17","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/S0264-410X(97)00143-6","article-title":"An immunogenicity and efficacy study of purified chick embryo cell culture rabies vaccine manufactured in Japan","volume":"15","author":"Benjavongkulchai","year":"1997","journal-title":"Vaccine"},{"issue":"Suppl A","key":"10.1016\/j.jiac.2019.05.004_bib18","first-page":"53","article-title":"Comparison of results for phase I studies with recombinant and plasma-derived hepatitis B vaccines, and controlled study comparing intramuscular and subcutaneous injections of recombinant hepatitis B vaccine","volume":"13","author":"Yamamoto","year":"1986","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2019.05.004_bib19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/00365548709117195","article-title":"Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response","volume":"19","author":"Wahl","year":"1987","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jiac.2019.05.004_bib20","first-page":"41","article-title":"Rabies and post-exposure prophylaxis in Thai children","volume":"7","author":"Thongcharoen","year":"1989","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jiac.2019.05.004_bib21","series-title":"Improvements in rabies post-exposure treatment","first-page":"129","article-title":"Study of the efficacy of a vaccine produced from rabies virus cultivated on Vero cell","author":"Chadli","year":"1985"},{"key":"10.1016\/j.jiac.2019.05.004_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1708-8305.2011.00522.x","article-title":"Rabies postexposure prophylaxis in a UK travel clinic: ten years' experience","volume":"18","author":"Wijaya","year":"2011","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.jiac.2019.05.004_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3947\/ic.2014.46.1.13","article-title":"Rabies post-exposure prophylaxis of overseas travelers in the international travel clinic of the national medical center from 2006 to 2012, Korea","volume":"46","author":"Park","year":"2014","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jiac.2019.05.004_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1708-8305.2007.00164.x","article-title":"Rabies postexposure prophylaxis in returned injured travelers from France, Australia, and New Zealand: a retrospective study","volume":"15","author":"Gautret","year":"2008","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.jiac.2019.05.004_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/jtm.12167","article-title":"Rabies postexposure consultations in New Zealand from 1998 to 2012","volume":"22","author":"Shaw","year":"2015","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.jiac.2019.05.004_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2310\/7060.2000.00011","article-title":"The Japanese need travel vaccinations","volume":"7","author":"Basnyat","year":"2000","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.jiac.2019.05.004_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1708-8305.2010.00405.x","article-title":"Knowledge, attitudes, and practices of Japanese travelers on infectious disease risks and immunization uptake","volume":"17","author":"Namikawa","year":"2010","journal-title":"J\u00a0Travel Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19301370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19301370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:55:25Z","timestamp":1778594125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19301370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1341321X19301370"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.05.004","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabies post-exposure prophylactic vaccination for returning travelers to Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}